Estrogen, cardiac protection and aging

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Estrogen loss and aging are inexorably linked. 17β-Estradiol (E2) can protect the heart from injury, but its effects are reduced in aging. Aging and estrogen loss contribute to a pro-inflammatory state and a decreased ability to handle ROS. This is further complicated by loss of the protective heat shock response with aging. E2 has many protective properties, including reducing cardiac injury and protecting the mitochondria, but the confounding effects of aging have not been well studied. E2 has a positive impact on pathologic cardiac hypertrophy and there are distinct differences in the roles of ERα and ERβ in hypertrophy, but whether this persists with aging is unknown. Clinically, postmenopausal women have an acceleration of atherosclerosis. Unexpectedly, double-blind randomized clinical trials of hormone replacement therapy (HRT) showed increased cardiovascular events and cancer with HRT. However HRT was initiated on average 10 years postmenopause and this likely contributed to the increase in cardiovascular events. Although our understanding of estrogen has come far over the last 20 years, much more basic research is needed to understand the consequences of aging and estrogen loss.

Original languageEnglish (US)
Title of host publicationIntegrative Biology of Women's Health
PublisherSpringer New York
Pages157-174
Number of pages18
ISBN (Print)9781461486305, 1461486297, 9781461486299
DOIs
StatePublished - Dec 1 2013

Fingerprint

Hormone Replacement Therapy
Estrogens
Heart Injuries
Postmenopause
Heat-Shock Response
Cardiomegaly
Hypertrophy
Estradiol
Atherosclerosis
Mitochondria
Randomized Controlled Trials
Wounds and Injuries
Research
Neoplasms

Keywords

  • Aging
  • Cytokines
  • Gene expression
  • Heat shock proteins
  • Mitochondria
  • ROS (reactive oxygen species)
  • SERMs

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Knowlton, A. A. (2013). Estrogen, cardiac protection and aging. In Integrative Biology of Women's Health (pp. 157-174). Springer New York. https://doi.org/10.1007/978-1-4614-8630-5_9

Estrogen, cardiac protection and aging. / Knowlton, Anne A.

Integrative Biology of Women's Health. Springer New York, 2013. p. 157-174.

Research output: Chapter in Book/Report/Conference proceedingChapter

Knowlton, AA 2013, Estrogen, cardiac protection and aging. in Integrative Biology of Women's Health. Springer New York, pp. 157-174. https://doi.org/10.1007/978-1-4614-8630-5_9
Knowlton AA. Estrogen, cardiac protection and aging. In Integrative Biology of Women's Health. Springer New York. 2013. p. 157-174 https://doi.org/10.1007/978-1-4614-8630-5_9
Knowlton, Anne A. / Estrogen, cardiac protection and aging. Integrative Biology of Women's Health. Springer New York, 2013. pp. 157-174
@inbook{3cef0e77db7148ce8f0b53ef58b8dcb5,
title = "Estrogen, cardiac protection and aging",
abstract = "Estrogen loss and aging are inexorably linked. 17β-Estradiol (E2) can protect the heart from injury, but its effects are reduced in aging. Aging and estrogen loss contribute to a pro-inflammatory state and a decreased ability to handle ROS. This is further complicated by loss of the protective heat shock response with aging. E2 has many protective properties, including reducing cardiac injury and protecting the mitochondria, but the confounding effects of aging have not been well studied. E2 has a positive impact on pathologic cardiac hypertrophy and there are distinct differences in the roles of ERα and ERβ in hypertrophy, but whether this persists with aging is unknown. Clinically, postmenopausal women have an acceleration of atherosclerosis. Unexpectedly, double-blind randomized clinical trials of hormone replacement therapy (HRT) showed increased cardiovascular events and cancer with HRT. However HRT was initiated on average 10 years postmenopause and this likely contributed to the increase in cardiovascular events. Although our understanding of estrogen has come far over the last 20 years, much more basic research is needed to understand the consequences of aging and estrogen loss.",
keywords = "Aging, Cytokines, Gene expression, Heat shock proteins, Mitochondria, ROS (reactive oxygen species), SERMs",
author = "Knowlton, {Anne A}",
year = "2013",
month = "12",
day = "1",
doi = "10.1007/978-1-4614-8630-5_9",
language = "English (US)",
isbn = "9781461486305",
pages = "157--174",
booktitle = "Integrative Biology of Women's Health",
publisher = "Springer New York",

}

TY - CHAP

T1 - Estrogen, cardiac protection and aging

AU - Knowlton, Anne A

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Estrogen loss and aging are inexorably linked. 17β-Estradiol (E2) can protect the heart from injury, but its effects are reduced in aging. Aging and estrogen loss contribute to a pro-inflammatory state and a decreased ability to handle ROS. This is further complicated by loss of the protective heat shock response with aging. E2 has many protective properties, including reducing cardiac injury and protecting the mitochondria, but the confounding effects of aging have not been well studied. E2 has a positive impact on pathologic cardiac hypertrophy and there are distinct differences in the roles of ERα and ERβ in hypertrophy, but whether this persists with aging is unknown. Clinically, postmenopausal women have an acceleration of atherosclerosis. Unexpectedly, double-blind randomized clinical trials of hormone replacement therapy (HRT) showed increased cardiovascular events and cancer with HRT. However HRT was initiated on average 10 years postmenopause and this likely contributed to the increase in cardiovascular events. Although our understanding of estrogen has come far over the last 20 years, much more basic research is needed to understand the consequences of aging and estrogen loss.

AB - Estrogen loss and aging are inexorably linked. 17β-Estradiol (E2) can protect the heart from injury, but its effects are reduced in aging. Aging and estrogen loss contribute to a pro-inflammatory state and a decreased ability to handle ROS. This is further complicated by loss of the protective heat shock response with aging. E2 has many protective properties, including reducing cardiac injury and protecting the mitochondria, but the confounding effects of aging have not been well studied. E2 has a positive impact on pathologic cardiac hypertrophy and there are distinct differences in the roles of ERα and ERβ in hypertrophy, but whether this persists with aging is unknown. Clinically, postmenopausal women have an acceleration of atherosclerosis. Unexpectedly, double-blind randomized clinical trials of hormone replacement therapy (HRT) showed increased cardiovascular events and cancer with HRT. However HRT was initiated on average 10 years postmenopause and this likely contributed to the increase in cardiovascular events. Although our understanding of estrogen has come far over the last 20 years, much more basic research is needed to understand the consequences of aging and estrogen loss.

KW - Aging

KW - Cytokines

KW - Gene expression

KW - Heat shock proteins

KW - Mitochondria

KW - ROS (reactive oxygen species)

KW - SERMs

UR - http://www.scopus.com/inward/record.url?scp=84930167375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930167375&partnerID=8YFLogxK

U2 - 10.1007/978-1-4614-8630-5_9

DO - 10.1007/978-1-4614-8630-5_9

M3 - Chapter

AN - SCOPUS:84930167375

SN - 9781461486305

SN - 1461486297

SN - 9781461486299

SP - 157

EP - 174

BT - Integrative Biology of Women's Health

PB - Springer New York

ER -